Search - tctmd.com

Displaying 1 - 20 of 27

Sort: Relevancy | Date

Presentation TVT 2023

The Stroke Issue and When to Consider Cerebral Embolic Protection Devices (CEPD)

Presenter: Tamim Nazif

June 07, 2023

News Conference News TVT 2022

More Support for Single Antiplatelet Therapy After TAVI

Michael O'Riordan

June 10, 2022

News Conference News TVT 2022

No Stroke Reduction With Embolic Protection in TAVI, Two Studies Suggest

Michael O'Riordan

June 09, 2022

News Conference News TVT 2021

New-Generation Watchman FLX Maintains Good Results Through 2 Years

Todd Neale

July 28, 2021

News Conference News TVT 2019

Real-world Stroke With TAVR: TVT Registry Insights Rekindle Cerebral Protection Debate

Shelley Wood

June 13, 2019

News Conference News TVT 2017

Q&A: Transcatheter Valve Innovation Past, Present, and Future as TVT Turns 10

Shelley Wood

June 12, 2017

Presentation TVT 2016

What Do I Do With a Patient With Cryptogenic Stroke?

Presenter: Creighton W. Don

June 18, 2016

Presentation TVT 2016

Strokes After TAVR: Etiologies, Declining Frequency, and Current and Future Therapies

Presenter: Samir R. Kapadia

June 17, 2016

Presentation TVT 2016

TVT 1039: Transcatheter Aortic Valve Replacement With Evolut-R CoreValve to Simultaneously Treat Severe Calcific Aortic Stenosis and a Large Aortic Root Pseudo-aneurysm in a High-risk Patient

Presenter: Nirat Beohar

June 17, 2016

Presentation TVT 2014

A Critical Analysis of Present Data on Cerebral Protection after TAVR

Presenter: Axel Linke

June 07, 2014

Presentation TVT 2014

Why Cerebral Protection after TAVR Will Become the Standard of Care

Presenter: Eberhard Grube

June 07, 2014

Presentation TVT 2014

Why Cerebral Protection after TAVR Will be Used Sparingly (if at all) in the Future

Presenter: Ganesh Manoharan

June 07, 2014

Presentation TVT 2014

A Rationale Approach to Adjunct Pharmacotherapy After TAVR (With Stroke in Mind)

Presenter: Susheel Kodali

June 07, 2014

Presentation TVT 2014

Has Stroke Frequency Declined After TAVR?

Presenter: Nicolas M. van Mieghem

June 07, 2014

Presentation TVT 2014

Perspectives from the US CoreValve Trials

Presenter: Jeffrey J. Popma

June 07, 2014

Presentation TVT 2014

Perspectives from the PARTNER Trials

Presenter: Susheel Kodali

June 07, 2014

Presentation TVT 2014

Incidence, Timing, Predictors (New Onset AF, Postdilatation, etc.), and Clinical Impact

Presenter: Samir R. Kapadia

June 07, 2014

Presentation TVT 2014

Stroke Basics after Cardiovascular Interventions: VARC 2 Definitions, Stroke Severity Assessment, Neuroimaging, and Neurocognitive Function

Presenter: Martin B. Leon

June 07, 2014

Presentation TVT 2013

The Keystone Deflector Device: Technology and Early Clinical Experiences

Presenter: Jeffrey Moses

June 12, 2013

Presentation TVT 2013

The Embrella Deflector Device: Technology and Early Clinical Experiences

Presenter: John Webb

June 12, 2013

Advertisement

The Stroke Issue and When to Consider Cerebral Embolic Protection Devices (CEPD)

More Support for Single Antiplatelet Therapy After TAVI

No Stroke Reduction With Embolic Protection in TAVI, Two Studies Suggest

New-Generation Watchman FLX Maintains Good Results Through 2 Years

Real-world Stroke With TAVR: TVT Registry Insights Rekindle Cerebral Protection Debate

Q&A: Transcatheter Valve Innovation Past, Present, and Future as TVT Turns 10

What Do I Do With a Patient With Cryptogenic Stroke?

Strokes After TAVR: Etiologies, Declining Frequency, and Current and Future Therapies

TVT 1039: Transcatheter Aortic Valve Replacement With Evolut-R CoreValve to Simultaneously Treat Severe Calcific Aortic Stenosis and a Large Aortic Root Pseudo-aneurysm in a High-risk Patient

A Critical Analysis of Present Data on Cerebral Protection after TAVR

Why Cerebral Protection after TAVR Will Become the Standard of Care

Why Cerebral Protection after TAVR Will be Used Sparingly (if at all) in the Future

A Rationale Approach to Adjunct Pharmacotherapy After TAVR (With Stroke in Mind)

Has Stroke Frequency Declined After TAVR?

Perspectives from the US CoreValve Trials

Perspectives from the PARTNER Trials

Incidence, Timing, Predictors (New Onset AF, Postdilatation, etc.), and Clinical Impact

Stroke Basics after Cardiovascular Interventions: VARC 2 Definitions, Stroke Severity Assessment, Neuroimaging, and Neurocognitive Function

The Keystone Deflector Device: Technology and Early Clinical Experiences

The Embrella Deflector Device: Technology and Early Clinical Experiences

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content